# Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy

> **NCT05749081** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **The First Affiliated Hospital of Nanchang University** · enrollment: 324 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Lacidophilin tablets in combination with vonorazan dual therapy
- **DRUG:** Placebo in combination with vonorazan dual therapy

## Key facts

- **NCT ID:** NCT05749081
- **Lead sponsor:** The First Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-13
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 324 (ESTIMATED)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05749081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05749081, "Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05749081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*